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Abstract
Although selective or whole body cooling combined with optimal intensive care improves outcomes following neonatal
encephalopathy in high-income countries, the safety and efficacy of cooling in low-and middle-income countries is not
known.
Objective: We performed a systematic review and meta-analysis of all published randomised or quasi-randomised
controlled trials of cooling therapy for neonatal encephalopathy in low-and middle-income countries.
Results: Seven trials, comprising a total of 567 infants were included in the meta-analysis. Most study infants had mild (15%)
or moderate encephalopathy (48%) and did not receive invasive ventilation (88%). Cooling devices included water-
circulating cooling caps, frozen gel packs, ice, water bottles, and phase-changing material. No statistically significant
reduction in neonatal mortality was seen with cooling (risk ratio: 0.74, 95% confidence intervals: 0.44 to 1.25). Data on other
neonatal morbidities and long-term neurological outcomes were insufficient.
Conclusion: Cooling therapy was not associated with a statistically significant reduction in neonatal mortality in low-and
middle-income countries although the confidence intervals were wide and not incompatible with results seen in high-
income countries. The apparent lack of treatment effect may be due to the heterogeneity and poor quality of the included
studies, inefficiency of the low technology cooling devices, lack of optimal neonatal intensive care, sedation and ventilatory
support, overuse of oxygen, or may be due to the intrinsic difference in the population, for example higher rates of perinatal
infection, obstructed labor, intrauterine growth retardation and maternal malnutrition. Evaluation of the safety and efficacy
of cooling in adequately powered randomised controlled trials is required before cooling is offered in routine clinical
practice in low-and middle-income countries.
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Introduction
Neonatal encephalopathy occurs in 1 to 3 per 1000 live births in
high-income countries, and in up to 20 per 1000 live births in low
and middle-income countries. Recent meta-analysis of therapeutic
cooling trials conducted in high-income countries show that
whole-body, or selective, head cooling reduces mortality (risk ratio
(RR) 0.78; (95% confidence intervals (CI) 0.66 to 0.93), and
improves survival with normal neurological outcome after
neonatal encephalopathy (RR: 1.53, (95% CI: 1.22 to 1.93)[1].
Cooling is also cost-effective in high-income countries [2], and its
protective effect persists into later childhood[3]. Cooling therapy is
now widely offered as standard treatment for neonatal encepha-
lopathy in high-income countries [4].
The burden of neonatal encephalopathy in low-and middle-
income countries is far higher than in high-income countries, and
it accounts for approximately one million deaths annually [5].
Although the health impact of cooling therapy may be substantial,
there are a number of concerns about the safety and efficacy of
cooling in low-and middle-income countries. Firstly, cooling is
combined with optimal tertiary neonatal intensive care in high-
income countries. Most low-and middle-income country neonatal
units do not have such facilities, and care may be sub-optimal.
Secondly, in low-and middle-income countries the therapeutic
time-window for administering beneficial cooling may be already
passed due to delayed hospital admissions, prolonged or obstruct-
ed labor, lack of neonatal transport facilities, and frequent
occurrence of intrauterine growth retardation. Thirdly, the
incidence of perinatal sepsis is far higher in low-and middle-
income countries, than in high-income countries, and neonatal
sepsis may masquerade as encephalopathy. The latter is partic-
ularly worrying considering the strong separate epidemiological
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associations between increased mortality and sepsis and hypother-
mia [6]. Finally, expensive servo-controlled cooling equipment
used in high-income countries is unsuitable for low-and middle-
income country use [7].
We performed a systematic review, and meta-analysis of the
published literature on the safety and efficacy of cooling therapy in
low-and middle-income countries.
Methods
We included all randomised, or quasi-randomised controlled
trials comparing either selective head or whole body cooling
(initiated within 6 hours of birth, and continued for at least
48 hours), with standard care, in term or near term infants with
neonatal encephalopathy consequential to perinatal asphyxia.
Asphyxia was considered if at least one of the following criteria
was met: Apgar score #5 at 5 min, cord or arterial blood pH
#7.1, base deficit $12 mmol/L within the first hour of life, or
ongoing resuscitation or mechanical ventilation at five minutes of
life. Neonatal encephalopathy was defined by detailed neurolog-
ical examination performed before randomisation. Studies without
a standard care arm were included in the systematic review, but
were excluded from the meta-analysis.
The primary outcomes were (i) neonatal mortality and (ii)
moderate or severe neurodevelopmental disability at $18 months
of age. Secondary outcomes were blood infections within the first
week of life, coagulopathy or thrombocytopenia requiring blood
products, respiratory failure requiring ventilator support, and
hypotension requiring intervention.
Search strategy and data analysis
We used standard Cochrane Neonatal review group (Issue 2,
2007) [8] methodology for literature search, data extraction,
quality assessment and meta-analysis. We searched Medline,
Embase, Cochrane Central Register of Controlled Trials (January
1995 to November 2012). We used the following search terms–
‘hypoxia-ischemia’, ‘newborn’, ‘hypothermia-induced’, and ‘de-
veloping countries’. We also examined expert reviews including
cross-references, abstracts, conference proceedings, and used
expert informants. No language restrictions were applied.
Two review authors (SSP/ST) independently identified the
studies to be included, extracted the data, and assessed the study
quality based on allocation concealment, blinding of outcome
assessment, adherence to intention to treat analysis, and
completeness and quality of follow up [8].
The effect of cooling therapy in settings that lack basic neonatal
care may be very different to those with good neonatal care.
Hence, we sub-grouped the studies based on the quality of
neonatal intensive care support (Level I, II and III) [9],and gross
national income of the country (GNI) using World Bank economic
classification (Upper middle income, Lower middle income, Low
income) [10] for minimising clinical heterogeneity. We used a
random effects model for meta-analysis because of the clinical
heterogeneity of included studies. Statistical heterogeneity was
quantified using the I2 test (RevMan version 5.1.4; Copenhagen).
We examined publication bias using a funnel plot [11]. A funnel
plot graphically checks the existence of publication bias in
systematic reviews and meta-analyses. It assumes that the largest
studies will have results near the average, and results from small
studies will be spread on both sides of the average. Variation from
this assumption can indicate publication bias.
Results
We identified a total of 18 studies on cooling therapy in low-and
middle-income countries, of which 11 were excluded (9 case series,
1 duplicate publication, 1 reported study protocol only). Thus we
analysed the data on 567 infants recruited to seven clinical trials
(3–selective head cooling, 4–whole body cooling; Figure 1). Details
of excluded studies are given in Table 1.
The study population included only full term infants (born at
$37 weeks gestation). The inclusion criteria for most of the studies
were low Apgar score at 5 minutes and evidence of encephalop-
athy within 6 hours after birth (Table 2). Four studies used
modified Sarnat staging and 2 used Thompson encephalopathy
score [12] to define encephalopathy; details of neurological
examination were not mentioned in 1 study. Two studies
[13,14] used only clinical inclusion criteria and did not include
blood tests (pH or base excess) to characterise the asphyxial event.
The mode of death (withdrawal of life support versus spontaneous
death) was not explicitly described in many studies. Characteristics
of the in-trial population are given in Table 3.
Cooling devices
Most studies used indigenous low technology cooling methods.
For whole-body cooling these included ice and frozen gel packs
Figure 1. Flow chart.
doi:10.1371/journal.pone.0058834.g001
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(n = 2) [15,16], cooling fan (n = 1) [17], water bottle (n = 1) [13],
and phase changing material (n = 1)[14]. The cooling method was
not reported in one study [18]. Selective head cooling used ice
around the head (n= 1) [19] or circulating-water head caps (n = 3)
[20–22].
Target rectal temperatures were 33 to 34uC [13–16,18] for
whole-body cooling and 36 to 36.5uC [19–22] for selective head
Table 1. Characteristics of excluded studies.
Excluded
studies Country
Cooling
method Device N Comments
Reasons for
exclusion
Horn[19] South
Africa
Selective head
cooling
Frozen gel packs 4 Study prematurely stopped due to wide temperature
fluctuations.
Case series
Horn[36] South
Africa
Selective head
cooling
Frozen gel packs 5 Pilot study of selective head cooling with frozen gel
packs around head
Case series
Horn[17] South
Africa
Selective head
cooling
Servo controlled
fan
10 Excessive shivering reported in the cooled infants. Case series
Thomas[16] India Whole body
cooling
Frozen gel packs 20 Recruited infants were $35 weeks gestation and
mean rectal temperature during cooling was
32.960.11uC.
Case series
Rajhans[37] India Whole body
cooling
Blanketrol II 5 Only two babies completed cooling for 72 hours Case series
Tan[24] Uganda Whole body
cooling
Water bottles 19 One year follow up of previously recruited infants
from a cooling trial.
Duplicate data
Robertson[23] Uganda Whole body
cooling
Water bottles 56 Study protocol of a previously published cooling trial. Protocol only
Horn[38] South
Africa
Selective Head
Cooling
Frozen gel packs 14 Active rewarming using a radiant warmer Case series
Thomas[16] India Whole body
cooling
Frozen gel packs 14 Long term follow up of a previous case series on
whole body cooling. Adverse outcome seen in 3
(2 deaths, 1 developmental delay) of the 14
infants (out of 20) followed up till 18 to 24
months of age
Case series
See [39] Malaysia Whole body
cooling
Ambient
temperature
17 Case series that mainly recruited Stage 2 NE infants,
cooled by manipulating environmental temperature;
report no neurological deficit in 14/15 stage 2 NE babies.
Case series
Li [40] China Whole body
cooling
ND 93 Hypothermic induced within 10 hours, maintaining
rectal temperature 33.5uC for 72 hours. No difference
in primary outcome of death or moderate-to-severe
disability whether hypothermia was started at 6 hours
or 6 to 10 hours.
Hypothermia
induced within
10 hours of age.
Study details
unclear.
ND, not described; NE, neonatal encephalopathy.
doi:10.1371/journal.pone.0058834.t001
Table 2. Major inclusion and exclusion criteria of studies included in the meta-analysis.
Akisu[20] Lin[21] Zhou[22] Robertson[13] Thayyil[14] Bharadwaj[15] Bhat[18]
Inclusion criteria
5 min Apgar ,6 AND
Cord pH,7.1 or base
deficit .10 mmol/L
AND encephalopathy
5 min Apgar ,6
AND Cord pH,7.1
or base deficit
.15 mmol/L AND
encephalopathy
5 min Apgar ,6
AND Cord pH,7 or
base deficit #16
mmol/L AND need
for resuscitation at
5 minutes of age
5 min Apgar
,6 AND
encephalopathy
(Thompson
score .5)
5 min Apgar
,6 AND
encephalopathy
(Thompson
score .5)
10 min Apgar
,6 AND arterial
pH#7 or base
excess $12 meq
AND
encephalopathy
10 minute
Apgar ,5 AND
Cord pH,7 and
or base deficit of
.18 meq/L
Exclusion criteria
Major congenital
malformation, metabolic
disorder, chromosomal
abnormalities, congenital
infection, transitory drug
depression
Major congenital
abnormalities,
persistent pulmonary
hypertension
Major congenital
abnormalities,
maternal fever
.38uC, infection,
rupture of
membranes .18
hours or foul
smelling liquor,
other encephalopathy
Apnoea or
cyanosis, absent
cardiac output
.10 min
Major congenital
malformations,
Imminent death
at time of
randomisation
Major congenital
abnormalities, no
spontaneous
respiration by 20
min, out born
babies
Not described
doi:10.1371/journal.pone.0058834.t002
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cooling. Detailed temperature profiles and re-warming methods
are given in Table 4. Control arm hyperthermia was not reported
in any study; however, one study noted hyperthermia during re-
warming of the cooled infants [21]. No data were available on
additional resource implications or nursing input required to
administer the cooling therapy.
Outcome measures
Primary outcome (neonatal mortality) was available from a total
of 567 infants recruited to the seven randomised controlled trials
[13–15,18,20–22]. The pooled data showed no difference in
neonatal mortality between the cooled and standard care infants
(RR: 0.74 (95% CI: 0.44 to 1.25) (Figure 2). However, the
confidence interval was wide and not incompatible with results for
high-income countries. There was no evidence of significant
statistical heterogeneity (I2 = 16%; p= 0.26). Data on encephalop-
athy stage was available from six trials – 15% of the infants had
mild, 48% moderate and 22% severe encephalopathy.
Three studies reported culture positive neonatal blood infec-
tions; again no significant difference was seen in infection rates
(RR 0.98 (95% CI 0.26 to 3.61) (Figure 3) [15,20,21], although the
confidence intervals were wide. The largest study excluded cases at
risk of early onset neonatal sepsis [23].
Four studies reported the use of respiratory support; only 12%
of infants were ventilated. Although, sedation was not routinely
given to all infants undergoing cooling therapy, some studies used
morphine [15], phenobarbitone [14,21] or chloral hydrate [14]
when babies were distressed.
The data were inadequate to examine other important short-
term secondary outcomes like coagulopathy, respiratory failure,
and hypotension. Zhou reported two cases with scalp edema and
scleroderma in their study using cooling caps [22].
Three studies reported long term neurodevelopmental out-
comes. Bharadwaj and Bhat reported adverse neurodevelopmental
outcome at age six months in 107 (82%) of the 130 infants in their
trial. Two cooled infants and 12 standard care infants had
developmental delay (Baroda developmental screening test) [15].
Tan et al. examined long-term outcomes at age one year for 19
(53%) of the 36 infants in their cooling trial. Specific assessment
details were not reported [24]. Zhou et al. reported 18-month
outcome data on 194 (76%) of the 256 infants they recruited:
severe disability in the cooled group (11/119) was similar to that in
age-matched controls (19/116); RR: 0.56 (95% CI: 0.28 to 1.3)
[22], although again confidence intervals were wide and differ-
ences of clinical importance could not be discounted.
Three trials were in upper mid income countries [20–22], three
in lower middle income countries [14,15,18], and one in a low-
income country [13]. The low-income country trial reported five
times higher mortality in the cooled infants (RR: 5, 95% CI: 0.7 to
37) [13] but this difference was not statistically significant. Data
were not available to perform sub group analysis based on the
quality of neonatal intensive care.
One study used quasi-randomisation based on whether recruit-
ment was on an odd or even calendar day [21]; five used
randomisation with sealed envelopes, and one used computerized
randomisation. All except one were small pilot (phase II) studies.
The results of the meta-analysis were heavily influenced by the
largest study [22], which was of poor quality. Although this was
the only phase III trial and used computerised randomization;
there was no assessor blinding, sealed envelopes were used on site,
and there were post randomization exclusions that may have
biased results. The study recruited 256 cases; 138 were allocated to
selective head cooling and 118 to standard care. Nineteen infants
were then excluded from the selective head cooling group and two
from the standard care group, before starting intervention. A
further 19 (16%) infants in the selective head cooling group, and
22 (19%) infants in the standard care group were lost to follow up
(Table 5).
Figure 2. Effect of cooling on neonatal mortality.
doi:10.1371/journal.pone.0058834.g002
Figure 3. Effect of cooling on neonatal sepsis.
doi:10.1371/journal.pone.0058834.g003
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Although no asymmetry was seen on the funnel plot (Figure 4),
only 7 studies were included in the meta-analysis. Hence no
definite conclusions about publication bias can be made [11].
Discussion
The pooled data from seven low-and middle-income country
randomised controlled cooling trials, including a total of 567
infants, did not show a statistically significant reduction in neonatal
mortality (RR 0.74; 95% CI 0.44 to 1.25); however the confidence
intervals were wide, thus clinically important benefits or harm
cannot be excluded. Most studies were small and/or of poor
quality, and did not evaluate long-term neurological outcomes or
other important neonatal morbidities.
Our data suggests that there are a number of key differences
between high-income country and low-and middle-income coun-
try cooling trials with regards to the study population, inclusion
criteria, and techniques used. For example, in low-and middle-
income country trials most recruited infants were reported to have
mild or moderate encephalopathy. More importantly, the vast
majority of the low-and middle-income country infants did not
require invasive ventilatory support, suggesting that the degree of
encephalopathy was much lower. This is in contrast with high-
income country cooling trials, and the current practice in high-
income countries where the vast majority of infants undergoing
cooling also require respiratory support. Alternatively, this may be
due to lack of facilities for providing optimal ventilatory support in
low-and middle-income countries. Sedation was not routinely used
with cooling in many studies, and this may be due to concerns
about respiratory compromise.
In addition, often babies were hypothermic at randomisation,
and the intrinsic hypothermia persisted for a few hours even in the
control arm of some studies. This may be due to lack of radiant
warmer facilities. Furthermore, unlike high-income country
cooling trials, no hyperthermia was reported in the standard care
infants. This may have diluted the net treatment effects of cooling.
Cooling was administered using a number of low-technology
devices; this included ice [19], fans [17], frozen gel packs [15],
water bottles [13], and phase changing material [14]. Selective
head cooling was more problematic with marked temperature
fluctuations, and hyperthermia during rewarming [21]. None of
the studies reported economic aspects, or any additional nursing
input required to use these cooling devices.
It is unclear whether the apparent lack of treatment effect, seen
in our meta-analysis can be attributed to the use of such low
technology devices, and possible inadvertent over or under
cooling. Although, one high-income country cooling trial had
previously reported the use of ice for whole body cooling [25], this
was within the setting of a well-resourced tertiary intensive care
unit with one-to-one nurse-to-infant ratio. It is possible that ice
cooling without such rigorous nursing monitoring may be
potentially dangerous and not neuroprotective during inadvertent
temperature fluctuations [19].
The lack of treatment effect (i.e. reduction in mortality) may be
also due to the heterogeneity and methodological weakness of the
studies included in this meta-analysis. Such a possibility cannot be
excluded due to wide confidence intervals of the pooled data.
Alternatively, there may be a genuine lack of treatment effect of
hypothermia in these settings. There are several arguments that
could support this hypothesis. For example, medically induced
hypothermia without optimal intensive care may be harmful. It is
possible that mechanical ventilation was underused or not
optimally monitored in these settings. High concentrations ofT
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oxygen [26] and lack of adequate sedation [27] might have also
negated the neuroprotective effects of hypothermia.
Another major concern of cooling therapy in low-and middle-
income country relates to the extensive literature on the
association of increased mortality with hypothermia, and a
potential worsening of sepsis with cooling [28]. The prevalence
and profile of perinatal sepsis (gram negative infections versus
group B streptococci) in LMIC is also different to that of high-
income countries [29]. Although, our meta-analysis does not
suggest an increase in blood stream infection with sepsis,
confidence intervals were wide, and therefore potential for harm
cannot be excluded. Moreover, the largest low-and middle-income
country cooling study excluded infants at high risk of early onset
neonatal sepsis. In addition, underlying maternal malnutrition,
fetal growth restriction, and obstruction of labor may co-exist with
hypoxia-ischemia in low-and middle-income countries, all of
which may influence the neuroprotective effects of cooling therapy
[30].
The lack of outcome data in many studies may be due to the
difficulty in undertaking long term follow-up in these settings.
Attrition rate in a cooling trial in sub Saharan Africa was
particularly high, and only 53% of the infants could be followed up
at one year of age [31].
A recent National Institute of Child Health and Human
Development workshop of cooling therapy experts concluded that
the safety and efficacy data on cooling from high-income countries
should not be extrapolated to low-and middle-income countries
[32]. Despite this, many clinicians have already offer cooling as a
clinical tool in low-and middle-income countries. A recent South
African survey reported that over 50% of clinicians offered cooling
in clinical practice [33]. Our meta-analysis suggests that current
data is insufficient to exclude significant harm or benefits of
cooling therapy in low-and middle-income countries, and there-
fore cooling therapy should be considered experimental and
should be offered only in the context of a rigorous randomised
controlled trial. Clearly, such studies should be conducted only in
settings where there is good basic neonatal care. Indeed, all except
one study in our meta-analysis appear to have been conducted in
tertiary neonatal units in middle-income countries. The only trial
conducted in a low income sub-Saharan neonatal unit that lacked
basic neonatal care, reported five times higher mortality in the
cooled infants [13]. Efforts should be focused on prevention of
encephalopathy by improving social factors and access to health
care, especially antenatal care in such settings [34]. Selective head
cooling is far more complex to administer than whole body
cooling, and offers no increased neuroprotection benefit or
reduced systemic side effects. There are appears to be little
justification for using selective head cooling in low-and middle-
income countries.
In summary, no reduction in neonatal mortality was seen
following selective head or whole body cooling after neonatal
encephalopathy in low-and middle-income countries, however,
confidence intervals were wide, and significant harm cannot be
excluded. Although, low technology devices effectively provided
whole body cooling, neuroprotective efficacy and additional
resource implications of these devices remain unclear. More
importantly, the clinical characteristics of encephalopathic infants
in low-and middle-income countries are different to that of high-
income countries, and therefore the safety and efficacy data on
cooling from high-income countries cannot be extrapolated to low-
Figure 4. Funnel plot of the included studies.
doi:10.1371/journal.pone.0058834.g004
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and middle-income countries. Adequately powered clinical trials
are required to before cooling can be considered as a therapeutic
option in low-and middle-income countries. One such multi-
country trial–‘HELIX’ (Hypothermia for Encephalopathy in Low
Income countries) is currently being set up [35]. However, until
more evidence from such trials are available, best practice
guidelines for use of therapeutic hypothermia in low-and middle-
income countries, jointly prepared by neonatologists in these
settings and cooling experts from high-income countries may be
required.
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